Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 6/2008

01-06-2008 | Original Article

Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats

Authors: Aditya Bansal, Wang Shuyan, Toshiko Hara, Robert A. Harris, Timothy R. DeGrado

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2008

Login to get access

Abstract

Purpose

[18F]Fluorocholine ([18F]FCH) was developed as an analog of [11C]choline for tumor imaging; however, its metabolic handling remains ill defined. In this study, the metabolism of [18F]FCH is evaluated in cultured 9L glioma cells and Fisher 344 rats bearing 9L glioma tumors.

Methods

9L glioma cells were incubated with [18F]FCH and [14C]choline under normoxic and hypoxic (1% O2) conditions and analyzed for metabolic fate. [18F]FCH and [14C]choline kinetics and metabolism were studied in Fisher 344 rats bearing subcutaneous 9L tumors.

Results

[18F]FCH and [14C]choline were similarly metabolized in 9L cells in both normoxic and hypoxic conditions over a 2-h incubation period. In normoxia, radioactivity was predominantly in phosphorylated form for both tracers after 5-min incubation. In hypoxia, the tracers remained mainly in nonmetabolized form at early timepoints (<20 min). Slow dephosphorylation of intracellular [18F]phosphofluorocholine (0.043–0.060 min−1) and [14C]phosphocholine (0.072–0.088 min−1) was evidenced via efflux measurements. In rat, both [18F]FCH and [14C]choline showed high renal and hepatic uptake. Blood clearance of both tracers was rapid with oxidative metabolites, [18F]fluorobetaine and [14C]betaine, representing the majority of radiolabel in plasma after 5 min postinjection. Oxidation (in liver) and lipid incorporation (in lung) were somewhat slower for [18F]FCH relative to [14C]choline. The majority of radiolabel in hypoxic subcutaneous tumor, as in hypoxic cultured 9L cells, was found as nonmetabolized [18F]FCH and [14C]choline.

Conclusions

[18F]FCH mimics choline uptake and metabolism by 9L glioma cells and tumors. However, subtle changes in biodistribution, oxidative metabolism, dephosphorylation, lipid incorporation, and renal excretion show moderate effects of the presence of the radiofluorine atom in [18F]FCH. The decrease in phosphorylation of exogenous choline by cancer cells should be considered in interpretation of positron emission tomography images in characteristically hypoxic tumors.
Literature
1.
go back to reference Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng. 2005;7:287–26.CrossRef Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng. 2005;7:287–26.CrossRef
2.
go back to reference DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110–7.PubMed DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110–7.PubMed
3.
go back to reference Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline–ether–phospholipid synthesis. Cancer Res. 2002;62(7):1966–70.PubMed Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline–ether–phospholipid synthesis. Cancer Res. 2002;62(7):1966–70.PubMed
4.
go back to reference Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res. 1996;16(3B):1375–80.PubMed Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res. 1996;16(3B):1375–80.PubMed
5.
go back to reference Hara T, Kosaka N, Kishi H. Development of 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43(2):187–99.PubMed Hara T, Kosaka N, Kishi H. Development of 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43(2):187–99.PubMed
6.
go back to reference Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296(3):580–3.PubMedCrossRef Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296(3):580–3.PubMedCrossRef
7.
go back to reference Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997;202(2):497–503.PubMed Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997;202(2):497–503.PubMed
8.
go back to reference Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38(6):842–7.PubMed Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38(6):842–7.PubMed
9.
go back to reference Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39(6):990–5.PubMed Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39(6):990–5.PubMed
10.
go back to reference Hara M. Clinical studies on cefoperazone and polymyxin B for the treatment of infections in patients with hematological malignancies. Jpn J Antibiot. 1987;40(9):1639–43.PubMed Hara M. Clinical studies on cefoperazone and polymyxin B for the treatment of infections in patients with hematological malignancies. Jpn J Antibiot. 1987;40(9):1639–43.PubMed
11.
go back to reference DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001;42(12):1805–14.PubMed DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001;42(12):1805–14.PubMed
12.
go back to reference Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, et al. PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006;33(11):1285–9. Jun 27.PubMedCrossRef Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, et al. PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006;33(11):1285–9. Jun 27.PubMedCrossRef
13.
go back to reference Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006;47(2):262–9.PubMed Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006;47(2):262–9.PubMed
14.
go back to reference Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, et al. Positron emission tomography/computed tomography with F-18 fluorocholine for restaging of prostate cancer patients: meaningful at PSA<5 ng/ml? Mol Imaging Biol. 2006;8(1):43–8.PubMedCrossRef Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, et al. Positron emission tomography/computed tomography with F-18 fluorocholine for restaging of prostate cancer patients: meaningful at PSA<5 ng/ml? Mol Imaging Biol. 2006;8(1):43–8.PubMedCrossRef
15.
go back to reference Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F] fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33(12):1387–98. July 25.PubMedCrossRef Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F] fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33(12):1387–98. July 25.PubMedCrossRef
16.
go back to reference Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology. 2005;235(2):623–8.PubMedCrossRef Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology. 2005;235(2):623–8.PubMedCrossRef
17.
go back to reference Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with fluorine-18 fluorocholine positron emission tomography. J Urol. 2005;173(1):252–5.PubMedCrossRef Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with fluorine-18 fluorocholine positron emission tomography. J Urol. 2005;173(1):252–5.PubMedCrossRef
18.
go back to reference Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004;14(3):285–9.PubMedCrossRef Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004;14(3):285–9.PubMedCrossRef
19.
go back to reference Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168(1):273–80.PubMedCrossRef Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168(1):273–80.PubMedCrossRef
20.
go back to reference Roivainen A, Forsback S, Gronroos T, Lehikoinen P, Kahkonen M, Sutinen E, et al. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000;27(1):25–32.PubMedCrossRef Roivainen A, Forsback S, Gronroos T, Lehikoinen P, Kahkonen M, Sutinen E, et al. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000;27(1):25–32.PubMedCrossRef
21.
go back to reference Jenkins WT, Evans SM, Koch CJ. Hypoxia and necrosis in rat 9L glioma and morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. Int J Radiation Oncology Biol Phys. 2000;46(4):1005–17. Jenkins WT, Evans SM, Koch CJ. Hypoxia and necrosis in rat 9L glioma and morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. Int J Radiation Oncology Biol Phys. 2000;46(4):1005–17.
22.
go back to reference Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell. 2006;21:521–31.PubMed Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell. 2006;21:521–31.PubMed
23.
go back to reference Lamprecht W, Trautschold I. Determination of ATP by hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. 2nd ed. New York: Academic; 1974. p. 2101–10. Lamprecht W, Trautschold I. Determination of ATP by hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. 2nd ed. New York: Academic; 1974. p. 2101–10.
24.
go back to reference Ishidate K, Nakazawa Y. Choline/ethanolamine kinase from rat kidney. Methods Enzymol. 1992;209:121–34.PubMed Ishidate K, Nakazawa Y. Choline/ethanolamine kinase from rat kidney. Methods Enzymol. 1992;209:121–34.PubMed
25.
go back to reference Haubrich DR, Wang PF, Wedeking PW. Distribution and metabolism of intravenously administered choline[methyl- 3-H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. J Pharmacol Exp Ther. 1975;193(1):246–55.PubMed Haubrich DR, Wang PF, Wedeking PW. Distribution and metabolism of intravenously administered choline[methyl- 3-H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. J Pharmacol Exp Ther. 1975;193(1):246–55.PubMed
26.
go back to reference Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. Regulation of the betaine content of rat liver. Arch Biochem Biophys. 1982;218(1):169–73.PubMedCrossRef Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. Regulation of the betaine content of rat liver. Arch Biochem Biophys. 1982;218(1):169–73.PubMedCrossRef
27.
go back to reference Garcia-Perez A, Burg MB. Role of organic osmolytes in adaptation of renal cells to high osmolality. J Membr Biol. 1991;119:1–13.PubMed Garcia-Perez A, Burg MB. Role of organic osmolytes in adaptation of renal cells to high osmolality. J Membr Biol. 1991;119:1–13.PubMed
28.
go back to reference Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. Faseb J. 1994;8(12):957–67.PubMed Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. Faseb J. 1994;8(12):957–67.PubMed
29.
go back to reference Pennington RJ, Worsfold M. Biosynthesis of lecithin by skeletal muscle. Biochim Biophys Acta. 1969;176(4):774–82.PubMed Pennington RJ, Worsfold M. Biosynthesis of lecithin by skeletal muscle. Biochim Biophys Acta. 1969;176(4):774–82.PubMed
30.
go back to reference Shamgar FA, Collins FD. Incorporation of ortho[32P]phosphate into phosphatidylcholines and phosphatidylethanolamines in rat skeletal muscle. Biochim Biophys Acta. 1975;409(1):104–15.PubMed Shamgar FA, Collins FD. Incorporation of ortho[32P]phosphate into phosphatidylcholines and phosphatidylethanolamines in rat skeletal muscle. Biochim Biophys Acta. 1975;409(1):104–15.PubMed
31.
go back to reference Hara T, Bansal A, DeGrado TR. Effect of hypoxia on uptake of [methyl-3H]choline, [1-14C]acetate and [18F]FDG in cultured prostate cancer cells. Nucl Med Biol. 2006;33(8):977–84. Nov.PubMedCrossRef Hara T, Bansal A, DeGrado TR. Effect of hypoxia on uptake of [methyl-3H]choline, [1-14C]acetate and [18F]FDG in cultured prostate cancer cells. Nucl Med Biol. 2006;33(8):977–84. Nov.PubMedCrossRef
32.
go back to reference Sarri E, Garcia-Dorado D, Abellan A, Soler-Soler J. Effects of hypoxia, glucose deprivation and acidosis on phosphatidylcholine synthesis in HL-1 cardiomyocytes. CTP: phosphocholine cytidylyltransferase activity correlates with sarcolemmal disruption. Biochem J. 2006;394(1):325–34. Feb 15.PubMed Sarri E, Garcia-Dorado D, Abellan A, Soler-Soler J. Effects of hypoxia, glucose deprivation and acidosis on phosphatidylcholine synthesis in HL-1 cardiomyocytes. CTP: phosphocholine cytidylyltransferase activity correlates with sarcolemmal disruption. Biochem J. 2006;394(1):325–34. Feb 15.PubMed
33.
go back to reference Jacobs RL, Lingrell S, Dyck JR, Vance DE. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation. J Biol Chem. 2007;282(7):4516–23. Feb 16.PubMed Jacobs RL, Lingrell S, Dyck JR, Vance DE. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation. J Biol Chem. 2007;282(7):4516–23. Feb 16.PubMed
Metadata
Title
Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats
Authors
Aditya Bansal
Wang Shuyan
Toshiko Hara
Robert A. Harris
Timothy R. DeGrado
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0736-y

Other articles of this Issue 6/2008

European Journal of Nuclear Medicine and Molecular Imaging 6/2008 Go to the issue

Announcement

Announcement